Testosterone for Women in Perimenopause: What the Evidence Says

Testosterone is often thought of as a male hormone, but women make it too, and it is one of the hormones that shifts during the menopause transition. So it is fair to ask whether topping it up can help. The honest, evidence-based answer is narrow. Across the major menopause societies, the one use that current evidence supports is distressing low sexual desire, once other causes have been looked at, using low, female-appropriate doses that are monitored with a doctor. Almost everything else you may have read is ahead of the science.

Testosterone Is a Female Hormone Too

Women produce testosterone in the ovaries and adrenal glands, and across the reproductive years a woman's blood testosterone is actually higher than her estrogen in absolute terms. It contributes to sexual desire and to a general sense of vitality. Testosterone levels decline gradually with age, starting well before menopause, rather than falling off a cliff at one moment. Because of that slow decline, and because the drop is not tightly tied to the menopause transition itself, a single testosterone blood level is not a reliable way to tell whether symptoms are caused by low testosterone. That is one reason the field is cautious.

What the Global Consensus Actually Says

In 2019 a large group of international medical societies published the Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Davis et al., 2019). It was endorsed by bodies including The Menopause Society (then the North American Menopause Society), the International Menopause Society, the Endocrine Society, and others, and it was built on a systematic review and meta-analysis of the randomized trial data (Islam et al., 2019). It remains the reference point clinicians use today.

Its central conclusion is deliberately narrow: the only indication for testosterone in women with enough evidence behind it is the treatment of hypoactive sexual desire dysfunction (HSDD), meaning low sexual desire that is persistent and genuinely distressing to the woman herself. For every other proposed benefit, the panel concluded the evidence was insufficient to recommend it.

The One Evidence-Backed Use: Distressing Low Desire

In the pooled trials, testosterone produced a modest but real improvement in sexual desire, arousal, orgasm, pleasure, and sexual satisfaction, and a reduction in sexual distress, in women who had HSDD. Most participants were postmenopausal. The key word is modest: this is a meaningful help for the right woman, not a dramatic transformation, and it is only appropriate when low desire is actually bothering her.

Just as important is the order of operations. Low desire in midlife usually has more than one cause, so testosterone is considered only after other contributors have been addressed. Those include relationship and life stress, mood and anxiety, sleep, certain medications (some antidepressants and hormonal contraceptives can lower desire), thyroid issues, and physical causes such as vaginal dryness or pain, which have their own effective treatments. A menopause-informed clinician will work through these first, because fixing the real driver often matters more than adding a hormone.

Where Perimenopause Fits In

Here is the honest nuance. The strongest evidence, and the trials behind the consensus, involve postmenopausal women. Testosterone use specifically in perimenopause, the years of fluctuating cycles before periods stop, is much less studied, and the consensus statement does not extend a firm recommendation to it. Some menopause specialists do consider it for perimenopausal women with distressing low desire on a case-by-case basis, but this is an individual clinical judgment rather than a settled, evidence-backed practice. If you are in perimenopause, it is reasonable to raise, and reasonable for a careful clinician to say the evidence here is thinner. Standard hormone therapy for estrogen-related symptoms is often considered first.

How It Is Used: Doses and Monitoring

When testosterone is prescribed for a woman, the guiding principle is to stay within the normal premenopausal female range, not to push levels higher. In most countries there is no testosterone product licensed specifically for women, so clinicians commonly prescribe a small, measured fraction of an approved male product, or a purpose-made female preparation where one is available. It is usually a cream or gel applied to the skin. The consensus is clear that oral (tablet) testosterone is not recommended, because of unfavorable effects on cholesterol.

Monitoring is part of doing it safely. Blood testosterone is typically checked before starting and again during treatment to confirm the level stays in range and to guard against too high a dose. At correct female doses, testosterone is generally well tolerated. If the dose is too high, the main side effects are acne and extra hair growth, which usually settle when the dose is reduced. Long-term safety data, particularly beyond about two years and for effects on the breast and heart, are limited, which is another reason ongoing review with a doctor matters.

What Is Not Established

This is where careful reading matters, because testosterone is heavily marketed to women for things the evidence does not support. The consensus panel specifically found insufficient evidence to recommend testosterone for the uses below. Insufficient evidence does not prove it never helps anyone; it means the studies do not currently justify prescribing it for these reasons.

So if a clinic or online seller promises that testosterone will fix your fatigue, lift your mood, sharpen your focus, or protect your bones, they are describing hopes, not proven results. The one thing the evidence points to is distressing low desire, and even there the effect is moderate.

How to Talk to Your Doctor

Testosterone for women sits in a genuinely nuanced place, so a good conversation is specific and unhurried. You can bring these points and questions.

Worth bringing

• How long your desire has been low, and whether it genuinely distresses you.
• What else is going on: sleep, mood, stress, relationship, medications, and any vaginal dryness or discomfort.
• Where you are in the transition, whether cycles are still happening but irregular (perimenopause) or have stopped.

Questions you can ask

• "Could something other than testosterone be driving my low desire, and should we address that first?"
• "Is standard hormone therapy worth trying before we consider testosterone?"
• "Given that most evidence is in postmenopausal women, how does that apply to me in perimenopause?"
• "If we try testosterone, what dose and form would you use, and how will you monitor my levels?"
• "What side effects should I watch for, and when would we stop or reassess?"

If your clinician is not comfortable with testosterone for women, which many are not, it is reasonable to ask for a referral to a menopause specialist who prescribes and monitors it regularly. Preparing well for that conversation makes a real difference.

Seeing Your Pattern with Peritale

Low desire rarely travels alone, and the whole point of a good testosterone conversation is separating what is driving what. Seeing your symptoms laid out over time is what makes that possible. Peritale gives you an objective, comprehensive picture of how the hormonal transition is affecting you, with no blood tests and nothing invasive at home. Using AI and a simple seven-minute process on a standard smartphone, it maps the effects on your cognitive performance (reaction speed, word retrieval, attention), your hearing and vision, and dozens of markers that computer vision reads across your skin, hair, and eyes, all alongside comprehensive symptom mapping. You get a complete snapshot that becomes your baseline, so you can talk to your doctor about what is really bothering you, take charge of your care, and start to feel like yourself again. Your first check is free.

The Bottom Line

Testosterone is a real hormone in women, and for a specific woman with distressing low sexual desire, given at low female-appropriate doses and monitored by a clinician, it can genuinely help. That is where the evidence stands today, and mostly in postmenopausal women, so its role in perimenopause is less certain. For energy, mood, memory, or bone health, the science is not there yet, whatever the marketing says. The wise move is to look at the whole picture, address the other drivers of low desire first, and make any decision about testosterone with a doctor who will dose and monitor it properly. This is education for awareness, not a diagnosis.

This content is for educational purposes only. Peritale is a general wellness product, not a medical device. It is not intended to diagnose, treat, cure, or prevent any disease. It does not measure hormones or prescribe treatment. Always consult a qualified healthcare provider for medical advice.